Keros Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:KROS) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 30.5 M46.01 M161.17 M-29.62 M3.25 M 180.81 M Cash from investing activities 386 K289 K565 K720 K132 K 1.71 M Cash from financing activities 155.94 M75.54 M4 00017 K140 K 75.7 M Free cash flow 30.11 M45.72 M160.61 M-30.34 M3.12 M 179.1 M

ニュース

Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?

Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?

SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD

Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?

Is KROS' KER-065 the Next Breakthrough in DMD Space?

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease

Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia

Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?

CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why